... or IBS. The syndrome affects 6 percent of middle school students and 14 percent of high ... 24 girls, between the ages of 12 and 18.
Irritable bowel syndrome causes discomfort in the abdomen, along ...
... highlight the safety and efficacy of probiotics in improving symptoms and normalizing bowel movement frequency in patients suffering from constipation or diarrhea related to Irritable Bowel Syndrome.
Fiber, antispasmodics and peppermint oil are all effective therapies for irritable bowel syndrome and should become first-line treatments, according to a new study.
... Hospital have discovered this correlation. The causes of what is known as irritable bowel syndrome (IBS), one of the most common disorders of the gastrointestinal tract, are considered unclear – ...
... . In the randomized, controlled trial, the efficacy of imipramine in the treatment of symptoms of irritable bowel syndrome (IBS) was studied. Patients diagnosed with IBS who failed treatment with ...
Irritable bowel syndrome has a strong connection to the mind.
Soluble fibre is the best line of defence in alleviating symptoms of irritable bowel syndrome, Dutch researchers say.
... , could lead to new therapies for the estimated one in five UK adults who have irritable bowel syndrome (IBS), a painful condition which is poorly understood. Symptoms of IBS include abdominal pain, ...
... on the left ventral forearm and left calf using an ascending method of limits. The Functional Bowel Disease Severity Index (FBDSI) was also obtained for all subjects.
The research revealed controls ...
WASHINGTON, April 30 (UPI) -- The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome.
... consultant in Toronto, battled frequent diarrhea and abdominal pain. Roberts, who suffers from irritable bowel syndrome, was unable to attend his children's soccer games and often had to cancel or ...
... significant relief of overall symptoms of Irritable Bowel Syndrome with Constipation (IBS-C). These results ... Approximately 58 million Americans have Irritable Bowel Syndrome (IBS), and IBS-C accounts ...
Scientists have developed a new approach to treating such autoimmune diseases as irritable bowel syndrome using genetically-engineered regulatory T cells. This approach may be adapted to a number of ...
... who suffer a bout of travelers' diarrhea are also at higher risk of developing irritable bowel syndrome, a chronic condition characterized by pain, bloating, diarrhea or constipation. Diarrheal ...
Persons with irritable bowel syndrome (IBS) can relieve their symptoms as effectively by following a self-administered, at-home cognitive behavioral program as they can by undergoing a 10-week in- ...
